Chengdu Olymvax Stock Hits Day Low Amid Price Pressure at CNY 26.30

Chengdu Olymvax Biopharmaceuticals, Inc. has experienced a notable decline today, with the stock dropping by 5.67% as of March 17, 2026. The stock reached an intraday low of CNY 26.30, reflecting a challenging trading session for the company. In terms of performance metrics, the stock has shown a significant decrease of 12.16% over the past week, contrasting with a modest decline of 1.78% in the China Shanghai Composite index. Over the last month, Chengdu Olymvax has remained relatively stable, with a slight decrease of 0.11%, while it has demonstrated impressive growth over the past year, boasting an increase of 82.61% compared to the broader market's 18.21% gain. The company, operating within the Pharmaceuticals & Biotechnology sector, has reported a robust growth in net sales of 25.38% and has achieved a return on capital employed (ROCE) of 6.86%. Despite today's downturn, Chengdu Olymvax has consistently outperformed the China Shanghai Composite over various time frames, indicating its strong market position.